In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...

Jennifer Davis is the first person to receive the breast cancer vaccine as part of a clinical trial. (Photo illustration: Yahoo News; photos: Getty Images) Finding a cure for cancer has been the holy ...

Adjuvant carboplatin added to standard anthracycline/taxane chemotherapy significantly improves outcomes in early ...

Patient-derived xenografts (PDX) may accurately predict early recurrence and survival outcomes in triple negative breast cancer (TNBC), offering a potential tool for tailoring treatment strategies to ...

A novel vaccine targeting triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms, has shown ...

Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease ...

Odds are you know someone who has had breast cancer, or maybe you're even a survivor yourself. But what if we told you there ...

Improved 3-year disease-free and recurrence-free survival seen with intensive chemotherapy regimen. HealthDay News — For patients with operative triple-negative breast cancer, a multigene signature ...

Triple-negative breast cancer does not respond to targeted breast cancer treatments, which limits treatment to primarily chemotherapy for now.

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

According to a Cleveland Clinic-issued statement, researchers with the institution have announced the final results of a ...

Finding a cure for cancer has been the holy grail in medicine for years. With the exception of the only two cancer vaccines currently available — one for HPV, strains of which can cause cancer, ...